La Jolla Pharmaceutical Co.

NASDAQ:LJPC   3:59:44 PM EDT
4.98
+0.25 (+5.28%)
Earnings Announcements

La Jolla Pharma Reports Qtrly Loss Per Share Of $0.43

Published: 11/09/2020 22:48 GMT
La Jolla Pharmaceutical Co (LJPC) - La Jolla Pharmaceutical Company Announces Financial Results for the Three and Nine Months Ended September 30, 2020.
La Jolla Pharmaceutical Co Qtrly Loss per Share $0.43.
La Jolla Pharmaceutical Co Qtrly Total Revenue $9.1 Million Versus $5.7 Million.
Revenue is expected to be $10.89 Million
Adjusted EPS is expected to be -$0.37

Next Quarter Revenue Guidance is expected to be $14 Million
Next Quarter EPS Guidance is expected to be -$0.28

More details on our Analysts Page.